↓ Skip to main content

A new indolocarbazole derivative in melanoma and carcinoma lung in vivo treatment

Overview of attention for article published in BMC Complementary Medicine and Therapies, April 2021
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
1 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A new indolocarbazole derivative in melanoma and carcinoma lung in vivo treatment
Published in
BMC Complementary Medicine and Therapies, April 2021
DOI 10.1186/s12906-021-03294-2
Pubmed ID
Authors

Anna Lantsova, Irina Golubeva, Larisa Borisova, Lyudmila Nikolaeva, Lydia Ektova, Maria Dmitrieva, Olga Orlova

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 April 2021.
All research outputs
#22,774,430
of 25,387,668 outputs
Outputs from BMC Complementary Medicine and Therapies
#3,205
of 3,960 outputs
Outputs of similar age
#393,419
of 454,911 outputs
Outputs of similar age from BMC Complementary Medicine and Therapies
#40
of 50 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,960 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 454,911 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 50 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.